Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway

• Main Authors: Jia Li (Author), Jiangtong Peng (Author), Shengnan Zhao (Author), Yi Zhong (Author), Yilong Wang (Author), Ji Hu (Author), Chao Zhang (Author), Min Cheng (Author), Geqing Xia (Author), Yu Hu (Author), Kai Huang (Author), Yan Wang (Author), Minglu Liang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tussilagone (TSL) is a sesquiterpenoid isolated from Tussilago farfara, which has been used as a traditional medicine for the treatment of asthma and bronchitis. It also takes part in the anti-inflammatory and antioxidant effects, but its role in angiogenesis is unknown. Angiogenesis is a cancer fea...